Physician profile
Izzat Chalabi
NPI 1184657157
$1,406.60
in general payments reported to CMS, 2019-2025
15 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $14.20 · 2021: $17.00 · 2022: $13.63 · 2023: $403 · 2024: $225 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $415.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $283.09 | 2023-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $154.28 | 2021-2023 | Ubrelvy, Qulipta |
| Sanofi-Aventis U.S. LLC | $118.37 | 2025 | |
| Amgen INC. | $90.69 | 2023-2025 | Otezla, Repatha, Otezla |
| Exact Sciences Corporation | $69.47 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $61.68 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.07 | 2019-2025 | Jardiance |
| Irhythm Technologies, INC. | $37.01 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $22.80 | 2024 | Airsupra |
| E.R. Squibb & Sons, L.L.C. | $22.15 | 2023 | Eliquis |
| Shield Therapeutics INC | $21.66 | 2023 | Accrufer |
| Merck Sharp & Dohme LLC | $19.71 | 2025 | Capvaxive, Gardasil 9 |
| Dynavax Technologies Corporation | $17.47 | 2025 | Heplisav-B |
| Novartis Pharmaceuticals Corporation | $14.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Izzat Chalabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.